Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.
about
Cobalamin deficiency, hyperhomocysteinemia, and dementiaLow levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearanceInvolvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's diseasebeta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation ProductThe Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular DementiaMicroglial cell dysregulation in brain aging and neurodegenerationThe Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationThe 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentElevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brainRole of methylglyoxal in Alzheimer's diseaseHsp70.1 and related lysosomal factors for necrotic neuronal deathOxidative stress in aging: advances in proteomic approachesEnhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading EnzymeAbeta, oxidative stress in Alzheimer disease: evidence based on proteomics studiesVitamin E, Turmeric and Saffron in Treatment of Alzheimer's DiseaseThe creatine kinase/creatine connection to Alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine depositsNeuroprotective properties of the marine carotenoid astaxanthin and omega-3 fatty acids, and perspectives for the natural combination of both in krill oilIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesHippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometryPhosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effectsMutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implicationRoles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition.Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease.Bacterial proteostasis balances energy and chaperone utilization efficientlyProtein disulfide bond formation in the cytoplasm during oxidative stress.Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid.Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuroblastoma cellsOxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Effects of 4-hydroxy-nonenal and Amyloid-beta on expression and activity of endothelin converting enzyme and insulin degrading enzyme in SH-SY5Y cells.Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation.Vascular endothelial barrier dysfunction mediated by amyloid-beta proteins.Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer diseaseSelective neuronal vulnerability to oxidative stress in the brain.Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases.Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.
P2860
Q24609123-3F2147CF-8A0C-49DE-8130-3F0DDA8DC745Q24626770-4A1E4EC5-CD01-47A9-842E-B0AC03FE33F0Q24684559-2895A79B-B5F6-474A-81AD-86F6AACB5FC8Q24803005-361F2BB1-AC7C-4EBE-AD54-86CC521D2146Q26782039-F2697851-A359-4E30-B88F-5FC7466C8A66Q26795415-18214213-8762-438C-91C2-DCA4B5FBCECEQ26800212-8D5FCE8F-3B3B-48D5-A08F-1A72D4E6CFD3Q26823454-12BB8E4A-519C-4B97-BE54-1FFBB528A9FCQ26827320-DB932190-44F4-41BC-B43A-54C75D357783Q27003253-6CF04B25-4DEE-4B46-B999-694BB3044972Q27004644-B4925A61-2C8B-4EE3-AE0A-F0306B741FF7Q27012978-889E70CB-3E7E-44F5-8CCA-A3C2AAF7783EQ27025199-EA9E8CAB-9F6F-4026-B1F9-40D29DD4DDC6Q27340023-0406E71C-BF79-43B2-A305-E45FB5ACC9B9Q27693922-C4517076-C812-4407-AE19-28842C0570B7Q28080306-A1701AC3-8E19-47A0-984D-858D5CC48B6DQ28200789-E393735E-7747-4FFB-A95D-4D0F134D7285Q28236740-3ABA151E-FD1E-4E7C-BA65-AE956235D996Q28388335-756964BE-0B5B-4AB4-8CDD-38892C1AD6ACQ28391606-D492F084-1385-4AD9-8AC2-111BFB4A21C9Q28482353-EDD19EFD-61C3-4C4B-8BF6-D6DB023D1D0FQ28510031-F26FDD26-560E-49A4-BAAE-6C7085E63889Q30394816-D68EE2EC-9DF2-45C1-90EE-00EB56BC435EQ30446460-CC9DD73E-8403-4CCB-9E7E-7E89822C498EQ30490908-1AC15151-2B79-42C6-A1CF-1D7CBAF2273FQ30499926-36FFC40F-C9B7-45D0-B97D-DD8CD00324C0Q30843998-5358477A-930D-4FCD-9699-3DEB9F2133F0Q33199830-EFC1AC52-5A65-482A-8B67-23926D419333Q33506441-D999F4B3-5860-445A-B0B1-7FBB2FB314F6Q33588687-26A03AC8-36C0-485E-AE28-464157ADEAE6Q33638710-0D21E427-CAF7-4729-815F-B09818D90098Q33639885-76572DCD-0EE9-4583-8FCF-020294D69896Q33642530-8421A57C-D083-4A22-A160-10AD9B385961Q33712475-60E16A19-DC51-4BF3-9BD1-C09EB28DF66BQ33747915-4893E610-2325-4250-9EF7-A22DE1D8C78DQ33780717-7B91B470-DA3C-4005-8EF3-D2D7C751307EQ33857238-CF059830-0075-4C95-B74C-8B370D3D1F09Q33868370-FFBB5C4D-042E-4B27-896D-0349AF9C5A6CQ33891870-DE474E43-3B8A-4B8B-9A23-D4250236E2C0Q33917550-5E0A2B1B-6434-4BD8-AB95-EE329AE6C870
P2860
Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Lipid peroxidation and protein ...... free radical oxidative stress.
@ast
Lipid peroxidation and protein ...... free radical oxidative stress.
@en
Lipid peroxidation and protein ...... free radical oxidative stress.
@nl
type
label
Lipid peroxidation and protein ...... free radical oxidative stress.
@ast
Lipid peroxidation and protein ...... free radical oxidative stress.
@en
Lipid peroxidation and protein ...... free radical oxidative stress.
@nl
prefLabel
Lipid peroxidation and protein ...... free radical oxidative stress.
@ast
Lipid peroxidation and protein ...... free radical oxidative stress.
@en
Lipid peroxidation and protein ...... free radical oxidative stress.
@nl
P1476
Lipid peroxidation and protein ...... free radical oxidative stress.
@en
P2093
Christopher M Lauderback
P304
P356
10.1016/S0891-5849(02)00794-3
P577
2002-06-01T00:00:00Z